SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 373 filers reported holding SAREPTA THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.81 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $19,180,034 | +86.1% | 158,225 | +75.9% | 0.15% | +68.5% |
| Q2 2023 | $10,303,591 | +514.6% | 89,972 | +639.7% | 0.09% | +456.2% |
| Q1 2023 | $1,676,425 | -91.1% | 12,163 | -91.7% | 0.02% | -89.8% |
| Q4 2022 | $18,891,598 | +142.0% | 145,791 | +106.5% | 0.16% | +141.5% |
| Q3 2022 | $7,807,000 | +43.5% | 70,616 | -2.7% | 0.06% | +22.6% |
| Q2 2022 | $5,441,000 | +107.0% | 72,602 | +115.7% | 0.05% | +120.8% |
| Q1 2022 | $2,629,000 | -28.3% | 33,665 | -17.3% | 0.02% | -27.3% |
| Q4 2021 | $3,665,000 | +1337.3% | 40,700 | +1139.7% | 0.03% | +1000.0% |
| Q2 2021 | $255,000 | -65.1% | 3,283 | -66.5% | 0.00% | -66.7% |
| Q1 2021 | $731,000 | -94.2% | 9,801 | -86.7% | 0.01% | -94.7% |
| Q4 2020 | $12,583,000 | +1278.2% | 73,809 | +1035.5% | 0.17% | +894.1% |
| Q3 2020 | $913,000 | +55.8% | 6,500 | +43.2% | 0.02% | +21.4% |
| Q4 2019 | $586,000 | -92.4% | 4,540 | -95.6% | 0.01% | -93.8% |
| Q3 2019 | $7,735,000 | -57.5% | 102,700 | -14.2% | 0.23% | -64.7% |
| Q2 2019 | $18,188,000 | +63.7% | 119,700 | +74.0% | 0.64% | +30.2% |
| Q3 2018 | $11,112,000 | -13.4% | 68,800 | -29.1% | 0.49% | -29.0% |
| Q2 2018 | $12,835,000 | +1902.3% | 97,100 | +1021.0% | 0.70% | +1350.0% |
| Q1 2018 | $641,000 | -87.2% | 8,662 | -90.4% | 0.05% | -88.3% |
| Q4 2017 | $5,008,000 | -44.7% | 90,000 | -55.0% | 0.41% | -50.4% |
| Q3 2017 | $9,063,000 | +2453.0% | 199,789 | +1568.8% | 0.83% | +2197.2% |
| Q1 2017 | $355,000 | +28.2% | 11,972 | +18.5% | 0.04% | 0.0% |
| Q4 2016 | $277,000 | -91.7% | 10,100 | -81.3% | 0.04% | -93.6% |
| Q3 2016 | $3,319,000 | +395.4% | 54,038 | +53.9% | 0.56% | +276.0% |
| Q2 2016 | $670,000 | – | 35,117 | – | 0.15% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ikarian Capital, LLC | 399,400 | $35,962,000 | 5.36% |
| Avoro Capital Advisors LLC | 3,125,000 | $281,406,000 | 4.79% |
| Varenne Capital Partners | 324,661 | $29,236,000 | 4.34% |
| Evolutionary Tree Capital Management, LLC | 96,695 | $8,707,000 | 4.18% |
| Ally Bridge Group (NY) LLC | 120,000 | $10,806,000 | 3.78% |
| Casdin Capital, LLC | 1,350,000 | $121,568,000 | 3.43% |
| Ghost Tree Capital, LLC | 100,000 | $9,005,000 | 3.23% |
| GREAT POINT PARTNERS LLC | 145,405 | $13,094,000 | 2.91% |
| Camber Capital Management LP | 825,000 | $74,291,000 | 2.55% |
| Alpha DNA Investment Management LLC | 17,522 | $1,577,000 | 1.00% |